11-94459466-G-GT
Variant summary
Our verdict is Pathogenic. The variant received 18 ACMG points: 18P and 0B. PVS1PM2PP5_Very_Strong
The NM_005591.4(MRE11):c.1441dupA(p.Thr481AsnfsTer6) variant causes a frameshift change involving the alteration of a conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. Variant has been reported in ClinVar as Likely pathogenic (★★). Synonymous variant affecting the same amino acid position (i.e. T481T) has been classified as Likely benign. Variant results in nonsense mediated mRNA decay.
Frequency
Consequence
NM_005591.4 frameshift
Scores
Clinical Significance
Conservation
Publications
- ataxia-telangiectasia-like disorder 1Inheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), G2P, Orphanet, Ambry Genetics
- breast cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
- familial ovarian cancerInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- hereditary breast carcinomaInheritance: AD Classification: NO_KNOWN Submitted by: ClinGen
- prostate cancerInheritance: AD Classification: NO_KNOWN Submitted by: Ambry Genetics
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 18 ACMG points.
Variant Effect in Transcripts
ACMG analysis was done for transcript: NM_005591.4. You can select a different transcript below to see updated ACMG assignments.
RefSeq Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MRE11 | NM_005591.4 | MANE Select | c.1441dupA | p.Thr481AsnfsTer6 | frameshift | Exon 13 of 20 | NP_005582.1 | ||
| MRE11 | NM_001440460.1 | c.1441dupA | p.Thr481AsnfsTer6 | frameshift | Exon 13 of 21 | NP_001427389.1 | |||
| MRE11 | NM_001440461.1 | c.1441dupA | p.Thr481AsnfsTer6 | frameshift | Exon 13 of 21 | NP_001427390.1 |
Ensembl Transcripts
| Selected | Gene | Transcript | Tags | HGVSc | HGVSp | Effect | Exon Rank | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|---|
| MRE11 | ENST00000323929.8 | TSL:1 MANE Select | c.1441dupA | p.Thr481AsnfsTer6 | frameshift | Exon 13 of 20 | ENSP00000325863.4 | ||
| MRE11 | ENST00000323977.7 | TSL:1 | c.1441dupA | p.Thr481AsnfsTer6 | frameshift | Exon 13 of 19 | ENSP00000326094.3 | ||
| MRE11 | ENST00000407439.7 | TSL:2 | c.1450dupA | p.Thr484AsnfsTer6 | frameshift | Exon 13 of 20 | ENSP00000385614.3 |
Frequencies
GnomAD3 genomes Cov.: 33
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251336 AF XY: 0.00 show subpopulations
GnomAD4 exome Cov.: 31
GnomAD4 genome Cov.: 33
ClinVar
Submissions by phenotype
Ataxia-telangiectasia-like disorder 1 Pathogenic:1
Hereditary cancer-predisposing syndrome Pathogenic:1
The c.1441dupA pathogenic mutation, located in coding exon 12 of the MRE11A gene, results from a duplication of A at nucleotide position 1441, causing a translational frameshift with a predicted alternate stop codon (p.T481Nfs*6). This alteration is expected to result in loss of function by premature protein truncation or nonsense-mediated mRNA decay. As such, this alteration is interpreted as a disease-causing mutation.
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at